Accelerated arteriosclerosis after transplantation: the possible role of calcium channel blockers.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  International Journal of Cardiology

• Publication date

  1997-12-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0167-5273(97)00250-7PMID 9488204
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunologic basis of transplant-associated arteriosclerosis.

  1996cited by this paper
• Accelerated atheromatous lesions in mouse hearts transplanted to apolipoprotein-E-deficient recipients.

  1996cited by this paper
• Frequency and characteristics of coronary thrombosis in the epicardial coronary arteries after cardiac transplantation.

  1996cited by this paper
• Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease.

  1996cited by this paper
• Atlas of cardiovascular pathology

  1996cited by this paper
• Morphological observations in the epicardial coronary arteries and their surroundings late after cardiac transplantation (allograft vascular disease)

  1996cited by this paper
• In vivo immunosuppressive mechanisms.

  1996cited by this paper
• The Registry of the International Society for Heart and Lung Transplantation: thirteenth official report--1996.

  1996cited by this paper
• New developments in the diagnosis and management of cardiac allograft vasculopathy.

  1995cited by this paper
• Calcium blockers and atherosclerosis: lessons from the Stanford Transplant Coronary Artery Disease/Diltiazem Trial.

  1995cited by this paper
• Crystal structures of human calcineurin and the human FKBP12–FK506–calcineurin complex

  1995cited by this paper
• An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy.

  1995cited by this paper
• Cardiac allograft vasculopathy: current concepts.

  1995cited by this paper
• Effect of pravastatin on outcomes after cardiac transplantation.

  1995cited by this paper
• X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex.

  1995cited by this paper
• Atherosclerosis progression/regression: lipoprotein and vessel wall determinants.

  1995cited by this paper
• Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex.

  1995cited by this paper
• NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes.

  1994cited by this paper
• Calcium channel blockers and coronary atherosclerosis: from the rabbit to the real world.

  1994cited by this paper
• Cardiac allograft vasculopathy assessed by intravascular ultrasonography and nonimmunologic risk factors.

  1994cited by this paper
• A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients.

  1993cited by this paper
• Immunosuppressive Properties of Calcium Channel Blockers

  1993cited by this paper
• IMMUNOSUPPRESSIVE PROPERTIES OF THE BENZOTHIAZEPINE CALCIUM ANTAGONISTS DILTIAZEM AND CLENTIAZEM, WITH AND WITHOUT CYCLOSPORINE, IN HETEROTOPIC RAT HEART TRANSPLANTATION

  1993cited by this paper
• Cardiac allograft vasculopathy.

  1993cited by this paper
• Amlodipine reduces graft coronary artery disease in rat heterotopic cardiac allografts.

  1993cited by this paper
• Impact of proximal or midvessel discrete coronary artery stenoses on survival after heart transplantation.

  1992cited by this paper
• Accelerated graft coronary artery disease: diagnosis and prevention.

  1992cited by this paper
• Transplant coronary disease: nonimmunologic risk factors.

  1992cited by this paper
• Hyperlipidemia after heart transplantation: report of a 6-year experience, with treatment recommendations.

  1992cited by this paper
• Transplant coronary disease: nonimmunologic risk factors.

  1992cited by this paper
• Additive inhibition of afferent and efferent immunological responses of human peripheral blood mononuclear cells by verapamil and cyclosporine.

  1991cited by this paper
• Amlodipine exerts a potent antimigrational effect on aortic smooth muscle cells in culture

  1991cited by this paper
• Calcium channel antagonists protect against the development of coronary artery disease following cardiac transplant

  1991cited by this paper
• In vitro models of anti-atherosclerotic effects of cardiovascular drugs.

  1990cited by this paper
• Protecting the vasculature: an eye toward the future.

  1990cited by this paper
• Synergistic immunosuppressive effect of low-dose cyclosporine A and the calcium antagonist nifedipine, mediated by the generation of suppressor cells.

  1990cited by this paper
• PULMONARY ARTERIOSCLEROSIS IN LONG‐TERM HUMAN HEART‐LUNG TRANSPLANT RECIPIENTS

  1989cited by this paper
• Functions of vascular wall cells related to development of transplantation-associated coronary arteriosclerosis.

  1989cited by this paper
• Interaction of cyclosporin and calcium antagonists.

  1989cited by this paper
• Morphology of solid organ allograft arteriopathy: identification of proliferating intimal cell populations.

  1989cited by this paper
• Retransplantation for severe accelerated coronary artery disease in heart transplant recipients.

  1988cited by this paper
• Calcium Antagonists and Low Density Lipoprotein Receptors

  1988cited by this paper
• Responses of coronary arteries of cardiac transplant patients to acetylcholine.

  1988cited by this paper
• Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings.

  1988cited by this paper
• Chronic rejection in human heart transplantation.

  1988cited by this paper
• Hyperlipidemia after heart transplantation.

  1988cited by this paper
• Inhibition of cholesteryl ester deposition in macrophages by calcium entry blockers: an effect dissociable from calcium entry blockade

  1987cited by this paper
• Inhibition of human natural killer (NK) activity by calcium channel modulators and a calmodulin antagonist.

  1987cited by this paper
• In vivo potentiation of cyclosporine immunosuppression by calcium antagonists.

  1987cited by this paper
• Nifedipine-induced hyporeactivity in delayed hypersensitivity skin tests.

  1987cited by this paper
• Clinical and laboratory correlates of accelerated coronary artery disease in the cardiac transplant patient.

  1987cited by this paper
• Long‐Term Effects of Verapamil on Aortic Smooth Muscle Cells Cultured in the Presence of Hypercholesterolemic Serum

  1987cited by this paper
• Preservation of Endothelium, Dependent Vascular Relaxation in Cholesterol, Fed Rabbit by Treatment with the Calcium Blocker PN 200110

  1986cited by this paper
• Verapamil Enhances Receptor‐Mediated Endocytosis of Low Density Lipoproteins by Aortic Cells in Culture

  1985cited by this paper
• Potentiation of cyclosporine by verapamil in vitro.

  1985cited by this paper
• Nifedipine increases cholesteryl ester hydrolytic activity in lipid-laden rabbit arterial smooth muscle cells. A possible mechanism for its antiatherogenic effect.

  1985cited by this paper
• Morphological patterns in cyclosporine-treated renal transplant recipients.

  1985cited by this paper
• The interference of T cell activation by calcium channel blocking agents.

  1984cited by this paper

• Current therapies for cardiac allograft vasculopathy in children.

  2012cites this paper
• Verapamil stereoisomers induce antiproliferative effects in vascular smooth muscle cells via autophagy.

  2012cites this paper
• Symptomatic acute myocardial infarction in a patient bearer of heart transplantation following ischemic heart disease.

  2008cites this paper
• Efecto del diltiazem sobre los lipidos sericos y lesiones ateroscleroticas en conejos hipercolesterolemicos

  2007cites this paper
• Transplantation cardiaque et cardiopulmonaire

  2006cites this paper
• Paclitaxel and cyclosporine A show supra-additive antiproliferative effects on smooth muscle cells by activation of protein kinase C

  2002cites this paper
• Effect of Calcium Antagonists on Ultrastructure of Myocardial Microvessels during Open Heart Surgery under Conditions of Pharmacological and Cold Cardioplegia

  2001cites this paper
• Transplantations cardiaque et cardiopulmonaire

  2000cites this paper
• Real-Time Magnetic Resonance Imaging: Diagnostic and Interventional Applications

  2000cites this paper
• Spontaneous combined hyperlipidemia, coronary heart disease and decreased survival in Dahl salt-sensitive hypertensive rats transgenic for human cholesteryl ester transfer protein

  1999cites this paper